Table of Contents
Toggle
Ally Hilbert
“Crafting content for cannabis & holistic wellness is not just about words; it’s about embedding genuine care into every paragraph, ensuring authenticity complements relevance, and converting intricate health concepts into easily understood insights for all.”
About
Ally Hilbert is the Content and SEO Manager here at Elevate Holistics, working to publish and run Elevate’s blogs and landing pages, as well as conduct keyword research, competitor analysis, and more. After having brain surgery at the age of 17, Ally became fascinated with medical cannabis and its benefits, and, at 18, had her first CBD-related piece published. Today, she’s been writing about cannabis for the past six years, and simply can’t think of a better company to get to do it for. When she’s not writing or editing, Ally’s side-by-side with her pup Sadie in Seattle.
Articles

Next Year, SXSW 2027 May Spotlight Cannabis and Psychedelics
South by Southwest just proved that cannabis at SXSW 2027 is no longer a niche conversation. Attendees can vote on seven panels that mention cannabis

Inside the Hemp Cannabinoid Ban 2026 and What It Means for HHC Consumers
Federal regulators and hemp companies are fighting over the fate of HHC, delta-8, and other synthetic cannabinoids sold nationwide. The DEA already assigned HHC its

VA Announces Psilocybin Therapy Trial for Veterans With Depression and PTSD
The Department of Veterans Affairs just opened a new clinical trial testing whether psilocybin can help veterans with treatment-resistant depression, including those who also live

Hemp THC Ban 2026: What the New Attorneys General Letter Means for You
A coalition of 35 state attorneys general just told Congress to leave the hemp THC ban 2026 alone. Their letter, published this week, urges lawmakers

Does Marijuana Legalization Increase Teen Use? Federal Studies Say No
A new federal report puts a persistent fear to rest. SAMHSA’s newly published 2025 National Survey on Drug Use and Health answers one of cannabis

Eli Lilly Just Spent $2.8 Billion on a Psychedelic Drug — Here’s Why That’s a Huge Deal
One of the largest drug companies in the world just made a $2.8 billion bet on a substance most people associate with underground rituals, not